Machine learning-assisted prediction of pneumonia based on non-invasive measures
Source check: Source checked. Not independent scientific confirmation.
Finding: A retrospective single-center cohort of 535 lower-respiratory-illness patients was classified as pneumonia versus bronchitis from non-invasive measures; the authors report cross-validated and held-out model performance. This is diagnostic evidence on the study sample, not prospective or clinical-utility validation.
Technology: Eight machine-learning classifiers distinguish pneumonia from bronchitis using clinical and laboratory measures.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Eight machine-learning classifiers distinguish pneumonia from bronchitis using clinical and laboratory measures.
- Test and result
- The paper reports experiments on 535 patients and performance metrics for RF/XGBoost on original and resampled data, with pneumonia/bronchitis as outcome classes.
- Limitation / still unknown
- The study reports five-fold cross-validation and an 80/20 training/test split on a retrospective single-center sample. This supports a bounded diagnostic-model result, but not generalization or clinical benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3389/fpubh.2022.938801 · https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.938801/full · https://pubmed.ncbi.nlm.nih.gov/35968461/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.